Verition Fund Management LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1454027 GREENWICH, CT

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,938,134

-$1,528,418 QoQ

Shares Held

299,199

-43.3% QoQ

Ownership

0.136%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $156,064,619 across 64 Biotechnology names. OCUL ranks #15 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	438,746	$30,997,404
2			159,256	$21,138,048
3	ABVX	Abivax S.A.	105,791	$14,097,708
4	IDYA	IDEAYA Biosciences, Inc.	184,054	$6,859,692
5	SNDX	Syndax Pharmaceuticals Inc	304,939	$6,665,966
6	MRVI	Maravai Lifesciences Holdings, Inc.	777,738	$4,853,085
7	CYTK	Cytokinetics Inc	54,889	$4,675,993
8	RPRX	Royalty Pharma plc	75,000	$4,205,250

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,938,134	299,199	-43.3%	Shares	Sole	2026-08-14
2026-03-31	$4,466,552	527,338	+207.3%	Shares	Sole	2026-05-15
2025-12-31	$2,083,296	171,606	+3.4%	Shares	Sole	2026-02-13
2025-09-30	$1,940,925	166,033	+11.7%	Shares	Sole	2025-11-14
2025-06-30	$1,379,026	148,602	+111.0%	Shares	Sole	2025-08-14
2025-03-31	$516,251	70,430	+12.7%	Shares	Sole	2025-05-15
2024-09-30	$543,758	62,501	+13.7%	Shares	Sole	2024-11-14
2023-06-30	$283,542	54,950	+214.0%	Shares	Sole	2023-08-14
2022-12-31	$49,180	17,502	+71.1%	Shares	Sole	2023-02-14
2022-09-30	$42,450	10,229	0.0%	Shares	Sole	2023-01-18
2022-06-30	$41,120	10,229	+2.3%	Shares	Sole	2022-08-30
2022-03-31	$49,500	10,000	0.0%	Shares	Sole	2022-06-02
2021-12-31	$69,700	10,000	—	Shares	Sole	2022-05-03
No filing history on record for this holder in this stock.